- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Algernon Pharmaceuticals Inc Class A (AGN)
Algernon Pharmaceuticals Inc Class A stock price live, this page displays CSE AGN stock exchange data. View the AGN premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Algernon Pharmaceuticals Inc Class A real time stock price chart below.
What Is the Algernon Pharmaceuticals Inc Class A Stock Price Today?
The Algernon Pharmaceuticals Inc Class A stock price today is 0.070.
What Is the Stock Symbol for Algernon Pharmaceuticals Inc Class A?
The stock symbol for Algernon Pharmaceuticals Inc Class A is ""AGN.""
What Stock Exchange Does Algernon Pharmaceuticals Inc Class A Trade On?
Algernon Pharmaceuticals Inc Class A is listed and trades on the CSE stock exchange.
Is Algernon Pharmaceuticals Inc Class A a Good Stock to Buy?
Determining whether Algernon Pharmaceuticals Inc Class A—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the AGN quote. (ISIN: CA01559R4008)
What Is the Algernon Pharmaceuticals Inc Class A Stock Price Today?
The Algernon Pharmaceuticals Inc Class A stock price today is 0.070.
What Is the Stock Symbol for Algernon Pharmaceuticals Inc Class A?
The stock symbol for Algernon Pharmaceuticals Inc Class A is ""AGN.""
What Stock Exchange Does Algernon Pharmaceuticals Inc Class A Trade On?
Algernon Pharmaceuticals Inc Class A is listed and trades on the CSE stock exchange.
Is Algernon Pharmaceuticals Inc Class A a Good Stock to Buy?
Determining whether Algernon Pharmaceuticals Inc Class A—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the AGN quote. (ISIN: CA01559R4008)
CSE
Currency in CAD
0.070
+0.005(+7.69%)
Closed·
Fair Value
An estimate of a Algernon Pharma's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.060
0.070
52 wk Range
0.055
0.130
AGN Scorecard
Full Analysis
Suffers from weak gross profit margins
AGN is not included in our AI-picked strategies. See which stocks are.
Review Strategies
Fair Value
An estimate of a Algernon Pharma's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.0600.070
52 wk Range
0.0550.130
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
AGN Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Algernon Pharma's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Neutral
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Net income is expected to drop this year
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Sell
Moving Averages
Neutral
Algernon Pharmaceuticals Inc Class A Company Profile
Algernon Pharmaceuticals Inc. operates as a clinical stage pharmaceutical development company in Canada and Australia. The company focuses on developing the therapeutic drugs in the areas of non-alcoholic steatohepatitis, liver disease, chronic kidney disease, and stroke program. It pipeline includes Ifenprodil, which is in Phase 2b clinical trial for the treatment of idiopathic pulmonary fibrosis and chronic cough; repirinast, which is in Phase 1 clinical trial for the treatment of chronic kidney disease; and N,N-Dimethyltryptamine, which is in Phase 1 clinical trial for the treatment of strokes and traumatic brain injuries. The company was formerly known as Breathtec Biomedical, Inc. and changed its name to Algernon Pharmaceuticals Inc. in July 2015. Algernon Pharmaceuticals Inc. was incorporated in 2015 and is headquartered in Vancouver, Canada.
Compare AGN to Peers and Sector
Metrics to compare | AGN | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipAGNPeersSector | |
|---|---|---|---|---|
P/E Ratio | −1.4x | −0.7x | −0.5x | |
PEG Ratio | −0.03 | 0.01 | 0.00 | |
Price/Book | 1.4x | 0.6x | 2.6x | |
Price / LTM Sales | - | 0.6x | 3.3x | |
Upside (Analyst Target) | - | 102.0% | 43.5% | |
Fair Value Upside | Unlock | 6.9% | 6.3% | Unlock |
Earnings
Latest Release
Jul 30, 2025
EPS / Forecast
-0.02 / --
Revenue / Forecast
-- / --
FAQ
What Stock Exchange Does Algernon Pharma Trade On?
Algernon Pharma is listed and trades on the Canadian Securities Exchange stock exchange.
What Is the Stock Symbol for Algernon Pharma?
The stock symbol for Algernon Pharma is "AGN."
What Is the Algernon Pharma Market Cap?
As of today, Algernon Pharma market cap is 2.40M.
What Is Algernon Pharma's Earnings Per Share (TTM)?
The Algernon Pharma EPS (TTM) is -0.07.
From a Technical Analysis Perspective, Is AGN a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.
How Many Times Has Algernon Pharma Stock Split?
Algernon Pharma has split 3 times.
How Many Employees Does Algernon Pharma Have?
Algernon Pharma has 0 employees.
What is the current trading status of Algernon Pharma (AGN)?
As of 05 Aug 2025, Algernon Pharma (AGN) is trading at a price of 0.07, with a previous close of 0.09. The stock has fluctuated within a day range of 0.06 to 0.07, while its 52-week range spans from 0.06 to 0.13.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.